These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 27503401

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Botulinum toxin type a and its uses in dry eye disease.
    Victoria AC, Pino A.
    Plast Reconstr Surg; 2012 Jul; 130(1):209e-210e. PubMed ID: 22743932
    [No Abstract] [Full Text] [Related]

  • 48. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm.
    Johnstone SJ, Adler CH.
    Headache; 1998 May; 38(5):366-8. PubMed ID: 9630789
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections.
    Diel RJ, Hwang J, Kroeger ZA, Levitt RC, Sarantopoulos CD, Sered H, Felix ER, Martinez-Barrizonte J, Galor A.
    Br J Ophthalmol; 2019 Aug; 103(8):1024-1029. PubMed ID: 30269099
    [Abstract] [Full Text] [Related]

  • 51. THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM.
    Gaćina K, Lešin M, Sarajčev D, Rotim N.
    Acta Clin Croat; 2022 Nov; 61(3):379-385. PubMed ID: 37492354
    [Abstract] [Full Text] [Related]

  • 52. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 53. Effect of Botulinum toxin A application in neuro-ophtalmologic indications on Schirmers test and tears osmolarity.
    Žiak P, Halička J, Kapitánová K, Mojžiš P.
    Cesk Slov Oftalmol; 2019 Apr; 75(2):74-77. PubMed ID: 31537075
    [Abstract] [Full Text] [Related]

  • 54. Demographic and clinical features of patients with blepharospasm in southern Taiwan: a university hospital-based study.
    Hwang WJ.
    Acta Neurol Taiwan; 2012 Sep; 21(3):108-14. PubMed ID: 23196730
    [Abstract] [Full Text] [Related]

  • 55. Electrophysiological studies in patients with blepharospasm before and after botulinum toxin A therapy.
    Behari M, Raju GB.
    J Neurol Sci; 1996 Jan; 135(1):74-7. PubMed ID: 8926500
    [Abstract] [Full Text] [Related]

  • 56. Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease.
    Choi EW, Yeom DJ, Jang SY.
    Medicina (Kaunas); 2021 Mar 08; 57(3):. PubMed ID: 33800125
    [Abstract] [Full Text] [Related]

  • 57. Duration of botulinum toxin effect in the treatment of crocodile tears.
    Nava-Castañeda A, Tovilla-Canales JL, Boullosa V, Tovilla-y-Pomar JL, Monroy-Serrano MH, Tapia-Guerra V, Garfias Y.
    Ophthalmic Plast Reconstr Surg; 2006 Mar 08; 22(6):453-6. PubMed ID: 17117101
    [Abstract] [Full Text] [Related]

  • 58. Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.
    Wabbels B, Fimmers R, Roggenkämper P.
    Toxins (Basel); 2022 Feb 07; 14(2):. PubMed ID: 35202148
    [Abstract] [Full Text] [Related]

  • 59. Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.
    Wabbels B, Roggenkämper P.
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan 07; 245(1):45-50. PubMed ID: 16874524
    [Abstract] [Full Text] [Related]

  • 60. Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm.
    Chundury RV, Couch SM, Holds JB.
    Ophthalmic Plast Reconstr Surg; 2013 Jan 07; 29(3):205-7. PubMed ID: 23552607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.